Sepragen to supply Pall Corp. with benchtop chromatography systems
Under the agreement, Sepragen will develop and manufacture bench top process development chromatography systems for Pall. The products, which augment Pall's extensive capabilities, will be sold and supported by Pall's global sales and technical support network...
HAYWARD, CA, Feb. 22, 2005 (BUSINESS WIRE) -- Sepragen Corp., a provider of patented technology and equipment for purification needs in the biotech and nutraceutical industries, has signed a multi-year agreement with filtration and purification industry leader, Pall Corp. Under the agreement, Sepragen will develop and manufacture bench top process development chromatography systems for Pall. The products, which augment Pall's extensive capabilities, will be sold and supported by Pall's global sales and technical support network.
Ken Frank, president of Pall BioPharmaceuticals said, "We are very pleased with our new alliance with Sepragen, which has a track record of developing innovative products for chromatography. The addition of these small-scale systems to our chromatography line expands our ability to satisfy customers' increasing needs for purification systems that span the drug development and production process." Products that scale up easily from the lab to the manufacturing floor are one key to the industry's ability to bring new drugs to market quickly.
Of this arrangement, Vinit Saxena, CEO of Sepragen, had this to say: "The Pall alliance provides validation of our technology, position and capability. The alliance will help us significantly enhance our revenue and, with the help of Pall's marketing and distribution channels, will enable us to take a greater share in the sizeable and rapidly growing biotech market."
Pall Corp. (www.pallcorp.com) is the global leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, semiconductors, water purification, aerospace and broad industrial markets. Total revenues are $1.8 billion. The company headquarters are in East Hills, N.Y., with extensive operations throughout the world.
Sepragen (www.sepragen.com) is a pioneer in bioseparations providing innovative equipment and instruments to biotech companies and processing know-how and technology to nutritional and dairy companies. The company holds over 14 patents related to its core technology.